Once Daily IV Busulfan and Fludarabine (IV Bu-Flu) Compares Favorably with IV Busulfan and Cyclophosphamide (IV BuCy2) as Pretransplant Conditioning Therapy in AML/MDS

We postulated that fludarabine (Flu) instead of cyclophosphamide (Cy) combined with IV busulfan (Bu) as preconditioning for allogeneic hematopoietic stem cell transplantation (HSCT) would improve safety and retain antileukemic efficacy. 67 patients received BuCy2 and subsequently 148 patients receiv...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Biol Blood Marrow Transplant
Päätekijät: Andersson, Borje S., de Lima, Marcos, Thall, Peter F., Wang, Xuemei, Couriel, Daniel, Korbling, Martin, Roberson, Soonja, Giralt, Sergio, Pierre, Betty, Russell, James A., Shpall, Elizabeth J., Jones, Roy B., Champlin, Richard E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2008
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4230823/
https://ncbi.nlm.nih.gov/pubmed/18489993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2008.03.009
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia